Article Abstract:
Warner-Lambert Co and Pfizer Inc is holding talks on a possible merger. A decision by Warner-Lambert to merge with Pfizer will be detrimental to American Home Products Corp (AHP), which was the first to propose a merger with Warner-Lambert. Warner-Lambert is being pressured by its shareholders to consider Pfizer's stock offer of $92.18 per share, which is significantly larger than AHP's offer of $63.59 per share.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Warner-Lambert Co's merger with American Home Products Corp is projected to be worth over $70 billion, so far the biggest transaction to occur in a rapidly merging drug industry. The new company, to be named American Warner, will be ranked as the No. 2 pharmaceutical company in the world with annual revenue of nearly $24 million. The deal requires the approval of both companies' board of directors as well as approval by shareholders and regulatory agencies.
User Contributions:
Comment about this article or add new information about this topic:
Article Abstract:
Warner-Lambert of Morris Plains, NJ, is trying to fend off Pfizer's hostile takeover bid by threatening to pull out of an agreement to jointly market Warner-Lambert's blockbuster cholesterol drug Lipitor. Pfizer derives about 40% of its annual profit from Lipitor, which was launched in 1997 and generates annual sales of $4 billion. By issuing the threat, observers say Warner-Lambert wants to exert more downward pressure on Pfizer's stock, which it is using for its hostile bid.
User Contributions:
Comment about this article or add new information about this topic: